Link Silicon Valley
The fastest way to connect to the people, companies and capital of Silicon Valley
Free 30 Day Trial Account
Sign Up | Log In
Search
 
My Lists

Mammoth Biosciences

1000 Marina Blvd, Suite 600
Brisbane, CA 94005
USA
Website Company Summary Management Team
Management

CEO: Trevor Martin (5/31/2017)
President/COO/Operations: Ted Tisch (7/31/2019)
Finance: Susan Wong (02/28/2021) ; Elaine Sun (03/31/2022)
Technology: Jesus Ching (5/31/2020) ; Janice Chen (7/31/2018) ; Peter Nell (11/30/2019)
General Counsel/Legal: Rachel Herder
Former Employees: Ashley Tehranch Karen Kirk
Board

Outside board: (May no longer be on the board) Tejas Maniar (Mayfield Fund venture capitalist)
Company

Business description: Mammoth Biosciences is harnessing the diversity of nature to power the next-generation of CRISPR products. Through the discovery and development of novel CRISPR systems, the company is enabling the full potential of its platform to read and write the code of life. Mammoth Biosciences aims to democratize disease detection with an easy and affordable point-of-care test that allows real-time and simultaneous detection of multiple conditions. By leveraging its internal research and development and exclusive licensing to Cas12, Cas13, and Cas14, Mammoth Biosciences can provide enhanced diagnostics and genome editing for life science research, healthcare, agriculture, biodefense and more. Based in South San Francisco, Mammoth Biosciences is co-founded by CRISPR pioneer Jennifer Doudna and principal founders Trevor Martin, Janice Chen, and Lucas Harrington. The firm is backed by top institutional investors including Mayfield, NFX, and 8VC, Decheng Capital and leading individual investors including Brook Byers, Tim Cook, and Jeff Huber.
Partners include: GSK
Capital

Rounds: 6
Recent Fundings: Sep 2021   Nov 2020
Capital raised: 264.0M
Last Round: 150.0M
Ownership: Private  
VCs include: Mayfield FundNational Institute of Health Navitas Capital Ulu Ventures Greenspring Associates LearnCapital ;  Decheng Capital Redmile Group Foresite Capital Initialized CapitalOMERS Ventures 8VC NFX;  Pacific 8 Ventures ;  Senator Investment Group Sixth Street
Corporate investors: First American;  MassMutual Ventures

Last Tweets


 

Last Mentions


Overview
Record updated: Sep 2021
Sector: Biotech
Year Founded: 2017
Headcount: 101-150 as of Sep 2021
Rounds: 6
Recent Fundings: Sep 2021   Nov 2020
Capital Raised: 264.0M
Last Round: 150.0M
Ownership: Private